Data sourced from Dakota Private Markets, the private fund performance platform powered by Dakota. Learn More | Request Access
Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota Private Markets centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is our weekly roundup of ten PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Top 10 Companies Likely to Transact (September 28 - October 1)
1. OnFinance AI
OnFinance AI is a generative AI company specializing in providing a proprietary large language model (LLM) called NeoGPT, designed specifically for the banking, financial services, and insurance (BFSI) industry. Founded in December 2022 by Anuj Srivastava and Priyesh Srivastava, the company is headquartered in Bengaluru, Karnataka, India. OnFinance AI's mission is to harness the power of generative AI to enhance regulatory compliance processes within the BFSI sector. Their flagship product, ComplianceOS, offers AI-powered solutions such as instant regulatory updates, intelligent evidence collection, smart task management, and AI-driven compliance reporting. These tools aim to streamline compliance workflows, improve productivity, and ensure adherence to regulatory standards. The company is committed to delivering secure and efficient AI solutions tailored to the unique needs of the BFSI industry.
- Sector: Information Technology
- Last known transaction date: Series A Venture, $4.2M, September 2025
- Why timing suggests a near-term transaction: This $4.2M Series A is modest for the stage, likely covering 12-18 months of runway under software-driven IT burn rates, possibly reflecting a lean, narrowly-scoped raise. A Series B raise is plausible in the late 2026 to early 2027 window, contingent on product and customer traction.
2. Time-travelling Milkman
Time-Travelling Milkman is a Netherlands-based company specializing in producing plant-based cream from sunflower seeds, serving as an ingredient for dairy alternatives. Their primary product, OleoCream TTM, is a sustainable dairy cream replacer made from sunflower seeds and water, offering a clean-label indulgence with no additives. The company focuses on providing natural, healthy, and sustainable creaminess to future-proof plant-based dairy products.
- Sector: Materials
- Last known transaction date: Seed Venture, $2.3M, September 2025
- Why timing suggests a near-term transaction: The $2.3M seed round is on the smaller side for a materials-sector venture, likely providing 12-18 months of runway given capital-intensive sector norms, suggesting a narrow scope. A Series A is plausible in the late 2026 to early 2027 window, tied to early technical validation.
3. Kapsera
Kapsera is a French AgTech startup founded in 2018 by Antoine Drevelle and Jérôme Bibette. The company specializes in developing innovative microencapsulation technologies to create sustainable and efficient bio-based products for agriculture, human nutrition, and animal nutrition. By stabilizing natural active substances, Kapsera aims to enhance the performance and environmental compatibility of bioinputs, addressing challenges such as the instability and inefficacy of bio-based solutions in field applications.
- Sector: Consumer Staples
- Last known funding round: Series A Venture, $1M, September 2025
- Why timing suggests a near-term transaction: This $1M Series A is unusually small for the stage, suggesting a bridge-style raise or narrow scope; runway is likely limited to 6-12 months under consumer staples burn rates. A follow-on raise is plausible as early as late 2025 to mid-2026, sooner than standard sector norms.
4. RefAssured
RefAssured, founded in 2022 by staffing industry veterans Brian Vesce, Nishad Amin, Dan Rothschild, and Tommy Semereaux, is a human capital services company headquartered in San Francisco, California. The company specializes in providing automated reference checking solutions and candidate performance insights tailored for the staffing sector. Their platform offers data-backed automated reference checks, performance evaluations, and redeployment solutions, aiming to enhance efficiency, speed placements, and improve hire quality for staffing agencies. RefAssured has experienced significant growth, doubling its revenue between 2024 and 2025 and expanding its customer base to include companies like Ingenovis Health, Fusion, and Triage. The company has processed over 1 million references, representing 20 million data points on candidate past performance. RefAssured's mission is to validate hiring decisions by providing accurate and transparent candidate insights, thereby improving the recruitment process for staffing agencies.
- Sector: Financials
- Last known funding round: Seed Venture, $3.3M, September 2025
- Why timing suggests a near-term transaction: The $3.3M seed round should fund roughly 12-18 months of runway consistent with capital-efficient financials-sector burn. A Series A is likely in the late 2026 to early 2027 window, pending regulatory or early traction milestones.
5. VedaBio
VedaBio is a biotechnology company specializing in molecular detection, aiming to revolutionize diagnostics and research by providing ultra-rapid, accurate results without the need for target amplification. Their flagship product, the CRISPR Cascade™, leverages engineered CRISPR enzymes to detect and amplify molecular targets, enabling highly multiplexed assays with analytical turnaround times under one minute.
- Sector: Health Care
- Last known funding round: Series A Venture, $25M, September 2025
- Why timing suggests a near-term transaction: This $25M Series A likely provides 24-30 months of runway, reflecting health care/biotech R&D and platform development capital intensity. A Series B is probable in the mid to late 2027 window, tied to technical or clinical milestones.
6. AudioShake
AudioShake is a San Francisco-based company specializing in AI-driven audio separation technologies. Their platform enables the extraction of individual components from audio recordings, such as vocals, instruments, and effects, facilitating applications like mixing, mastering, localization, and interactive experiences. Serving artists, music publishers, film studios, and app developers, AudioShake enhances audio accessibility and interactivity.
- Sector: Information Technology
- Last known funding round: Series A Venture, $14M, October 2025
- Why timing suggests a near-term transaction: The $14M Series A should fund 18-24 months of runway under software-driven IT burn rates. A Series B raise is plausible in the mid to late 2027 window, contingent on product adoption and revenue growth.
7. Predicta Biosciences
Predicta Biosciences is a precision oncology company founded in 2023, specializing in integrating multiomics and liquid biopsy technologies to develop innovative diagnostic and therapeutic solutions for blood cancers. Their platform enables non-invasive, blood-based diagnostics that replace traditional bone marrow biopsies, guiding optimal immunotherapy decisions.
- Sector: Health Care
- Last known funding round: Series A Venture, $23.4M, October 2025
- Why timing suggests a near-term transaction: This $23.4M Series A likely provides 24-30 months of runway, reflecting health care R&D and clinical-stage capital intensity. A Series B is probable in the late 2027 to early 2028 window, tied to data readouts or regulatory progress.
8. Apiphani Inc.
Apiphani Inc. is a technology-enabled managed services provider specializing in mission-critical application management. Founded in 2018 by CEO Justin Folkers, the company is headquartered in Boston, Massachusetts. Apiphani offers a range of services, including application support, cloud strategy, cybersecurity, and data analytics. Their proprietary AI-driven platform, Deep Automation™, automates routine IT operations, enhancing efficiency and reliability for clients. In 2024, Apiphani ranked No. 173 on the Inc. 5000 list, marking a three-year revenue growth of over 2,210%.
- Sector: Information Technology
- Last known funding round: Series A Venture, $25M, October 2025
- Why timing suggests a near-term transaction: The $25M Series A should fund 18-24 months of runway under software-driven IT burn rates. A Series B raise is likely in the mid to late 2027 window, contingent on enterprise traction and revenue scale.
9. Cyvl
Cyvl is a Boston-based company specializing in infrastructure asset management. They provide AI-powered solutions that enable governments, engineering firms, and businesses to digitize and manage transportation infrastructure efficiently, facilitating faster and more accurate data-driven decisions.
- Sector: Industrials
- Last known funding round: Series A Venture, $14M, October 2025
- Why timing suggests a near-term transaction: This $14M Series A likely covers 18-24 months of runway consistent with industrials-sector capital intensity. A Series B is probable in the mid to late 2027 window, tied to commercial deployment and unit economics.
10. Viboo
viboo is a Swiss climate tech startup specializing in enhancing building energy efficiency through its Predictive Control as a Service (PCaaS) platform. By integrating smart thermostats and advanced algorithms, viboo optimizes heating and cooling systems, achieving energy savings of up to 40% in both residential and light commercial buildings.
- Sector: Information Technology
- Last known funding round: Seed Venture, $3.3M, October 2025
- Why timing suggests a near-term transaction: The $3.3M seed round should provide 12-18 months of runway under software-driven IT burn rates. A Series A raise is plausible in the late 2026 to early 2027 window, contingent on early product-market fit signals.
Use Dakota Private Markets' Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota Private Markets' private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
This dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
Filter by sector, geography, funding stage, last transaction date, or parent sponsor to build the list that matches your mandate.
To explore more companies likely to transact, request access to Dakota Private Markets.
